Merck & Co’s CEO Kenneth Frazier has said the pharma industry must take on the challenge of its poor public perception. In an interview with Yahoo Finance, Frazier defended the industry’s ...
Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey Sonnenfeld and co-author Steven Tian.
Fortune on MSN16d
The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and MerckPfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.
Merck & Co’s CEO Kenneth Frazier has warned that the drugs and vaccines in the pipeline to combat COVID-19 may not be enough to swiftly end the pandemic. Speaking to CNBC, Frazier said that the ...
As the nation kicks off Black History Month, a look into the industry shows there is a significant lack of Black leaders.
two Black pioneering business leaders – former Merck CEO Ken Frazier and former American Express CEO Ken Chenault – told CNN. “At its best, DEI is about developing talent, measuring it in a fair way ...
Mukherjee, the Pulitzer prize-winning oncologist who has also written treatises on genetic and cellular research, will serve as Manas’ CEO ... Merck’s former chairman and chief, Ken Frazier ...
"As a former CEO in the biopharma ... discovery model", said Ken Frazier, chairman, health assurance initiatives, General Catalyst, and former chairman and CEO of Merck. "Manas AI has the ...
two Black pioneering business leaders – former Merck CEO Ken Frazier and former American Express CEO Ken Chenault – told CNN. “At its best, DEI is about developing talent, measuring it in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results